Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL

Recruiting now

Conditions studied: Ph Positive ALL

In brief

The objective of this retrospective study is to examine the outcome of patients who relapse with Ph+ ALL and to potentially identify response profiles in order toadvance the treatment regimens that can be offered.

Key facts

Study ID

NCT07433400

Run by

Group for Research in Adult Acute Lymphoblastic Leukemia

People needed

500

Starts

2025-08-29

Expected to finish

2035-12-31

Last updated by the study team

2026-02-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >= 18
• Relapse or refractory Ph1 ALL

You may not qualify if…

• none

Where it is running

• GRAALL — Pierre-Bénite, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.